Clinical Trials Directory

Trials / Unknown

UnknownNCT06209931

RIRS With Tip Flexible Pressure-controlling Ureteral Access Sheath Versus Mini PCNLfor Kidney Stones

Retrograde Intrarenal Surgery With Tip Flexible Pressure-controlling Ureteral Access Sheath Versus Mini Percutaneous Nephrolithotomy for the Treatment of 2-3-cm Kidney Stones

Status
Unknown
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
The Affiliated Ganzhou Hospital of Nanchang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The goal of this observational study is to compare the safety and efficacy between RIRS with tip flexible pressure-controlling ureteral access sheath and mini percutaneous nephrolithotripsy(PCNL) for the treatment of 2-3-cm kidney stones.

Detailed description

Retrograde Intrarenal Stone Surgery (RIRS) has become one of the most common treatments for renal stones. The development of ureteral access sheath (UAS) is a significant advance in RIRS. In recent years, various improvements have been made to UAS, especially the emergence of a suction UAS and a tip flexible UAS. Using the advantages of suction and tip flexible technology, our team developed a tip flexible pressure-controlling UAS, which significantly improves the safety and effectiveness of RIRS. However, the current guidelines can recommend the indication of RIRS in kidney stones less than 2cm, and percutaneous nephrolithotomy(PCNL) is still preferred for kidney stones larger than 2 cm. Therefore, this study is the first to compare the safety and efficacy between RIRS with tip flexible pressure-controlling UAS and mini PCNL in the treatment of 2 to 3 cm kidney stones.

Conditions

Interventions

TypeNameDescription
PROCEDURERIRSRIRS with tip flexible pressure-controlling ureteral access sheath versus mini PCNL for the treatment of 2-3-cm kidney stones

Timeline

Start date
2023-10-01
Primary completion
2024-10-01
Completion
2024-12-01
First posted
2024-01-18
Last updated
2024-01-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06209931. Inclusion in this directory is not an endorsement.